Markets Brace for Trio of Economic Releases GDP Revision PCE Inflation and Oil Inventories on May 28 Jim Cramer Explores Link Between Dollar General DG and Iran Tensions Stanley Druckenmiller Sells Nvidia Pivots to These 3 AI Infrastructure Stocks Red Cross Volunteers Succumb to Suspected Ebola in DR Congo Raising Economic Risk Concerns Vestas Wind Systems Shares Slide After Margin Guidance Revision Google Employee Charged in 1 Million Polymarket Insider Trading Bet Over Search Term LTC Q1 2026 Earnings EPS Misses Estimates as Revenue Data Unavailable Waystar Holding Corp WAY Q1 2026 Earnings EPS Surpasses Estimates Shares Gain 39 NEON Q1 2026 Earnings EPS Misses Estimates Amid Elevated Operating Costs LivePerson Q1 2026 Earnings EPS Beat Drives Positive Stock Move Amid Continued Turnaround AI Q1 2026 Earnings EPS Misses Estimates as Subscription Momentum Drives Stock Higher LeonaBio Inc LONA Q1 2026 Earnings NarrowerThanExpected Loss Buoyed by RD Progress Chain Bridge Bancorp CBNA Edges Higher as Stock Holds Above Critical Support INNOVATE Corp VATE Gains 374 as Price Approaches Key Resistance Level International Flavors Fragrances IFF Holds Steady Near Support Amid Sector Resilience Scully Royalty Ltd SRL Stalls at 612 Trading in a Tight Range Near Support Ironwood Pharmaceuticals IRWD Slides 49 as Support Levels Tested Near 352 Kohls Struggles in Competitive Retail Landscape after Q1 2026 Earnings NextPlat Corp Q1 2026 Earnings Negative EPS of 042 Amid No Revenue Disclosure Stock Rises Over 16 Helmerich Payne HP Slips 109 Support and Resistance Levels in Focus ARE Q1 2026 Earnings Massive EPS Surprise Highlights Operational Strength Quoin Pharmaceuticals Ltd Q1 2026 Earnings NarrowerThanExpected Loss Amid PreRevenue Phase IRIX Q1 2026 Earnings EPS Surprises to the Upside Despite Limited Revenue Disclosure NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending BOOM Q1 2026 Earnings EPS Surprise of 155 Despite Net Loss Stock Edges Lower LTRN Q1 2026 Earnings EPS Beat Expectations as Biotech Focuses on Pipeline Progress